克服血脑屏障:针对质瘤的向输送策略
Xue Du1, Chunbao Chen2, Yijun Zeng2
1Department of Oncology and Hematology, The 3RD Affiliated Hospital of Chengdu Medical College, Chengdu Pidu District People's Hospital, Chengdu, China.
Frontiers in pharmacology
|December 10, 2025
概括
新型药物输送系统为治疗恶性质瘤提供了新的希望,克服了血脑屏障和瘤异质性挑战. 本综述探讨了纳米载体,向输送和基因疗法,以改进质瘤治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 纳米医学是一种纳米医学.
- 生物技术是生物技术.
背景情况:
- 质瘤是最常见和最致命的原发性脑瘤.
- 治疗挑战包括血脑屏障 (BBB) 和高瘤异质性.
- 新的药物输送系统显示出克服这些障碍的希望.
研究的目的:
- 审查新型药物输送系统在质瘤治疗中的进展情况.
- 分析各种交付策略的优势和挑战.
- 为优化未来质瘤治疗提供见解.
主要方法:
- 对用于药物输送的纳米载体的审查.
- 对有针对性的交付策略的分析.
- 检查基因治疗药物输送系统.
主要成果:
- 纳米载体,向输送和基因疗法代表了关键的进展.
- 每个系统在克服BBB和瘤异质性方面都有独特的优势和挑战.
- 在开发这些新型系统方面取得了重大进展.
结论:
- 新型药物输送系统对于推进质瘤治疗至关重要.
- 需要进一步的研究来优化这些系统的临床应用.
- 这些策略为管理恶性质瘤提供了一个有希望的未来.
更多相关视频
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
2.9K
06:41Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery
Published on: January 31, 2017
11.5K
相关概念视频
00:49The Blood-brain Barrier
52.1K
Overview
52.1K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K